Ironwood Pharmaceuticals, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
13.00
|
|
Average Rating
|
3.60
|
|
# Strong Buys
|
1
|
|
# Buys
|
1
|
|
# Holds
|
3
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
0.27
|
0.28
|
0.01
|
3.70%
|
|
2022-06-30
|
0.30
|
0.21
|
-0.09
|
-30.00%
|
|
2022-03-31
|
0.26
|
0.21
|
-0.05
|
-19.23%
|
|
2021-12-31
|
0.35
|
0.27
|
-0.08
|
-22.86%
|
|
2021-09-30
|
0.31
|
0.33
|
0.02
|
6.45%
|
|
2021-06-30
|
0.23
|
0.34
|
0.11
|
47.83%
|
|
2021-03-31
|
0.21
|
0.24
|
0.03
|
14.29%
|
|
2020-12-31
|
0.29
|
0.36
|
0.07
|
24.14%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
0.70
|
|
2021-12-31
|
1.18
|
|
2020-12-31
|
0.79
|
|
2019-12-31
|
0.54
|
|
2018-12-31
|
-0.95
|
|
2017-12-31
|
-0.93
|
|
2016-12-31
|
-0.56
|
|
2015-12-31
|
-1.00
|
|
2014-12-31
|
-1.39
|
|
2013-12-31
|
-2.33
|
|
2012-12-31
|
-0.71
|
|
2011-12-31
|
-0.66
|
|
2010-12-31
|
-0.63
|
|
2009-12-31
|
-3.30
|